Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
KRAS
Biotech
BridgeBio taps VCs for $200M to fund cancer-focused spinout
BridgeBio has secured $200 million to equip a cancer-focused offshoot to push a pipeline led by a KRAS inhibitor through early-phase tests.
Nick Paul Taylor
May 2, 2024 7:00am
Jacobio's KRAS data tee up safety-focused lung cancer pitch
May 1, 2024 7:01am
AACR: KRAS inhibitors pop in preclinical data debuts
Apr 11, 2024 4:30am
Frontier CEO weathers one of his hardest fundraises to add $80M
Feb 22, 2024 4:01pm
Jazz jumps into KRAS G12D space via $10M upfront deal with Redx
Feb 7, 2024 8:30am
Hookipa, reeling from Roche's KRAS cull, lays off 30% of team
Jan 29, 2024 9:21am